News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Deep Breeze™: Novel Software Application Extends VRI(TM) Capabilities to Predicting Post-Operative Lung Function



3/18/2009 11:03:31 AM

MANNHEIM, Germany--(BUSINESS WIRE)--Deep Breeze Ltd., manufacturer of the FDA approved VRIxp™ & VRIxv™ lung imaging systems, announced that it has received CE mark for its O-Plan application extending the usefulness of Deep Breeze's revolutionary VRI™ technology to patients eligible for lung cancer resection. The application has recently received the CE mark and it is used by thoracic surgeons in European Union countries.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES